Literature DB >> 4623790

Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.

E F Pfeiffer, S Raptis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4623790     DOI: 10.1007/bf01219985

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  [Flow equilibrium in the circulating blood].

Authors:  F H DOST
Journal:  Dtsch Med Wochenschr       Date:  1962-09-14       Impact factor: 0.628

2.  A new diagnostic procedure for mild diabetes mellitus; evaluation of an intravenous tolbutamide response test.

Authors:  R H UNGER; L L MADISON
Journal:  Diabetes       Date:  1958 Nov-Dec       Impact factor: 9.461

3.  The diagnostic value of sodium tolbutamide in hypoglycemic states.

Authors:  S S FAJANS; J M SCHNEIDER; D E SCHTEINGART; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

4.  Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

5.  [Significance of a single dose as an indication for the suitability of oral diabetic therapy].

Authors:  E F PFEIFFER; K SCHOFFLING; H STEIGERWALD; H DITSCHUNEIT; F HEUBEL
Journal:  Dtsch Med Wochenschr       Date:  1957-09-06       Impact factor: 0.628

6.  [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].

Authors:  K H PFEFFER; K J FUCHS; W MICHEL; H K FOERDER
Journal:  Arztl Wochensch       Date:  1957-03-22

Review 7.  [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1969-09

8.  Determination of free and antibody-bound insulin in insulin treated diabetic patients.

Authors:  L G Heding
Journal:  Horm Metab Res       Date:  1969-05       Impact factor: 2.936

9.  [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors:  H Mehnert; E Karg
Journal:  Dtsch Med Wochenschr       Date:  1969-04-18       Impact factor: 0.628

10.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15
View more
  2 in total

1.  Human C-peptide. Part II: Clinical studies.

Authors:  W Beischer; E Heinze; L Keller; S Raptis; W Kerner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-08-01

2.  [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].

Authors:  W Beischer; S Raptis; L Keller; M Maas; B Beischer; K Feilen; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1978-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.